Niacinamide
Niacinamide (also known as nicotinamide) is the water-soluble amide form of Vitamin B3. While it functions as an essential nutrient for tissue respiration and lipid metabolism, its primary use in veterinary pharmacology is as an **immunomodulator**. In canine medicine, it is most frequently prescribed in synergistic combination with **tetracycline** (or doxycycline) to manage immune-mediated dermatologic conditions. It is particularly effective for **discoid lupus erythematosus (DLE)** and **pemphigus erythematosus**, showing efficacy in 25% to 65% of affected dogs. > **Clinical Pearl:** It is critical to distinguish niacinamide from niacin (nicotinic acid). Unlike niacin, niacinamide does *not* cause cutaneous vasodilation (the "niacin flush") and does not affect blood lipid levels or the cardiovascular system, making it the appropriate and safe choice for long-term immunomodulation in dogs.
Mecanismo: At pharmacologic doses, niacinamide exerts anti-inflammatory and immunomodulatory effects through several pathways: * **Mast Cell Stabilization:** Blocks **IgE-induced histamine release** and prevents the degranulation of mast cells. * **Enzyme Inhibition:** Inhibits **phosphodiesterase (PDE)** enzymes → increases intracellular cAMP → decreases the release of inflammatory proteases. * **Synergy with Tetracyclines:** When used concurrently with tetracycline or doxycycline, the combination suppresses leukocyte chemotaxis that occurs secondary to complement activation by antibody-antigen complexes. * **Nutritional Role:** Acts as a precursor to NAD and NADP, essential coenzymes for tissue respiration, glycogenolysis, and lipid metabolism.
Dosificación por especie
- Discoid lupus erythematosus · For dogs weighing 10 kg or more: 500 mg of niacinamide and 500 mg of tetracycline PO q8h. For dogs weighing from 5-10 kg: 250 mg of each drug PO q8h. For dogs weighing less than 5 kg: 100 mg of each drug PO q8h. · PO · q8h · Improvement usually noted within 6 weeks · Given in combination with tetracycline.
- Discoid lupus erythematosus or pemphigus · Dogs weighing more than 10 kg: 500 mg of niacinamide and 500 mg of tetracycline PO q8h. For dogs weighing less than 10 kg: 250 mg of each PO q8h. · PO · q8h · May use in combination with corticosteroids and Vitamin E. If adverse effects become a problem, reduce dose of niacinamide first.
- Various immune-mediated diseases (DLE, pemphigus, vasculitis, dermatomyositis, etc.) · For dogs less than 10 kg: 250 mg each of niacinamide and tetracycline PO three times daily. For dogs larger than 10 kg: 500 mg each of niacinamide and tetracycline PO three times daily. · PO · TID · May substitute doxycycline for tetracycline at 5 mg/kg PO once a day.
- Pemphigus foliaceous · Doses as above (with prednisone and azathioprine). Once remission has occurred the dose may be gradually tapered to once daily administration. · PO · TID initially, taper to q24h · Improvement within 1-2 months · Used as adjunctive therapy.
- Adjunctive therapy for pemphigus or discoid lupus erythematosus · 100 mg of each for dogs <5kg; 250 mg of each for dogs 5-10 kg; 500 mg of each for dogs >10 kg PO three times daily until resolve (90-120 days), then decrease by one dose per day per month (three times daily to two times daily to once daily and eventually to every other day for 30-60 days.) · PO · TID initially, then tapered · 90-120 days initially, then 30-60 days taper · Given with tetracycline.
- Immunomodulation (e.g., lupoid onychodystrophy, discoid lupus erythematosus, pemphigus foliaceus) · 250 mg/dog (dogs up to 25 kg), 500 mg/dog (dogs >25 kg) · PO · q8h · Taper to effect · Often used in combination with oxytetracycline, tetracycline, or doxycycline.
Vías de administración
Contraindicaciones
- Liver disease
- Active peptic ulcers
- Hypersensitivity to niacinamide
- Do not use nicotinic acid (niacin) as a substitute due to severe vasodilation (flushing) effects.
Efectos adversos
- Anorexia
- Vomiting
- Lethargy
- Elevated liver enzymes (occasional)
- Increased seizure frequency (anecdotal)
- Mild gastrointestinal irritation (anorexia, vomiting, diarrhea)
Interacciones farmacológicas
- Insulin · May require dosage adjustments after initiating niacinamide therapy due to potential alterations in glycemic control.
- Oral Antidiabetic Agents · May require dosage adjustments after initiating niacinamide therapy.
Monitoreo
- Clinical efficacy (resolution of dermatologic lesions)
- Adverse effects (GI upset, lethargy)
- Liver enzymes (baseline and occasional monitoring suggested)
- Clinical resolution of dermatological lesions
- Gastrointestinal signs (vomiting, diarrhea, anorexia)
- Liver enzymes (if used long-term or at high doses)
Sobredosis
Acute toxicity is rare. Overdoses are unlikely to cause significant problems other than acute gastrointestinal distress (vomiting, diarrhea).
La referencia de fármacos de VetSheet está destinada a médicos veterinarios como apoyo a la decisión clínica; no sustituye el juicio profesional ni la información vigente del fabricante.